At what CAGR is the MEA anti-fungal agents market projected to grow in the forecast period (2023-2030)?

The MEA anti-fungal agents market is projected grow at approximately 5.5% CAGR during the assessment period (2023-2032). Read More

How much is the anti-fungal agents market in the MEA worth in the future?

The valuation of the MEA anti-fungal agents market is estimated to increase to USD 6.88 billion by the end of 2032. Read More

Who are the top players in the MEA anti-fungal agents market?

Pfizer, Inc., Novartis AG, Sanofi-Aventis, Enzon Pharmaceuticals, Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc, Astellas Pharma, Inc., Abbott, and Sigma-Aldrich, are some of the major players operating in the MEA anti-fungal agents market. Read More

Which region holds the largest share in the MEA anti-fungal agents market?

The UAE holds the largest share in the MEA anti-fungal agents market, followed by Egypt and the rest of Africa, respectively. Read More

What are the major tailwinds pushing the growth of the MEA anti-fungal agents market?

Growing awareness among populaces, rising prevalence of fungal infections, and off label use of broad spectrum antibiotics are the major tailwinds pushing the growth of the MEA anti-fungal agents market. Read More

MEA Anti Fungal Agents Market

Anti-Fungal Agents Market Research Report Information, by Therapeutic Indication (Aspergillosis, Dermatophytosis, Candidiasis and Others), Drug Class (Azoles, Pyrimidines, Echinocandins, Polyenes, Allylamines and Others) and Route of Administration (Oral, Local and Others) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

5.17%

2024 Market Size

$ 20.5 Billion

2035 Market Size

$ 35.7 Billion

Pharmaceutical ● Updated August 2026 Report ID: MRFR/Pharma/1942-HCR | Pages: 84 | Author: Satyendra Maurya, Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 Introduction
1. 1.1 Definition
2. 1.2 Scope of Study
3. 1.3 Research Objective
4. 1.4 Assumptions & Limitations
5. 1.5 Market Structure:
2 Research Methodology
1. 2.1 Research Process
2. 2.2 Primary Research
3. 2.3 Secondary Research
3 Market Dynamics
1. 3.1 Drivers
2. 3.2 Restraints
3. 3.3 Opportunities
4. 3.4 Challenges
5. 3.5 Macroeconomic Indicators
4 Market Factor Analysis
1. 4.1 Porter’s five forces model
  1. 4.1.1 Bargaining Power of suppliers
  2. 4.1.2 Bargaining Power of Customer
  3. 4.1.3 Intensity of Competitor’s
  4. 4.1.4 Threat of New Entrants
5 MEA Anti Fungal Agents Market, by Therapeutic Indication
1. 5.1 Introduction
  1. 5.1.1 Aspergillosis
  2. 5.1.2 Dermatophytosis
  3. 5.1.3 Candidiasis
  4. 5.1.4 Others
6 MEA Anti Fungal Agents Market, by Drug Class
1. 6.1 Introduction
  1. 6.1.1 Azoles
  2. 6.1.2 Pyrimidines
  3. 6.1.3 Echinocandins
  4. 6.1.4 Polyenes
  5. 6.1.5 Allylamines
  6. 6.1.6 Others
7 MEA Anti Fungal Agents Market, by Route of Administration
1. 7.1 Introduction
  1. 7.1.1 Oral
  2. 7.1.3 Local
  3. 7.1.4 Others
8 Middle MEA Anti Fungal Agents Market, by Country
1. 8.1 Introduction
2. 8.2 UAE
3. 8.3 Egypt
4. 8.4 Saudi Arabia
5. 8.5 Kuwait
6. 8.6 Qatar
7. 8.7 Oman
9 Company Landscape
1. 9.1 Introduction
  1. 9.1.1 Mergers Acquisitions
  2. 9.1.2 Collaborations
  3. 9.1.3 Release/New Product Launches
  4. 9.1.4 Other (Expansion, Updates, Partnership)
10 Company Profile
1. 10.1 Novartis AG
  1. 10.1.1 Company Overview
  2. 10.1.2 Product/Business Segment Overview
  3. 10.1.3 Financials
  4. 10.1.4 Key Developments
  5. 10.1.5 SWOT Analysis
2. 10.2 Pfizer, Inc.
  1. 10.2.1 Overview
  2. 10.2.2 Product/Business Segment Overview
  3. 10.2.3 Financials
  4. 10.2.4 Key Developments
  5. 10.2.5 SWOT Analysis
3. 10.3 Sanofi-Aventis
  1. 10.3.1 Overview
  2. 10.3.2 Product/Business Segment Overview
  3. 10.3.3 Financials
  4. 10.3.4 Key Developments
  5. 10.3.5 SWOT Analysis
4. 10.4 Merck & Co.
  1. 10.4.1 Overview
  2. 10.4.2 Product/Business Segment Overview
  3. 10.4.3 Financials
  4. 10.4.4 Key Developments
  5. 10.4.5 SWOT Analysis
5. 10.5 Enzon Pharmaceuticals
  1. 10.5.1 Overview
  2. 10.5.2 Product/Business Segment Overview
  3. 10.5.3 Financials
  4. 10.5.4 Key Developments
  5. 10.5.5 SWOT Analysis
6. 10.6 Bayer AG
  1. 10.6.1 Overview
  2. 10.6.2 Product/Business Segment Overview
  3. 10.6.3 Financials
  4. 10.6.4 Key Developments
  5. 10.6.5 SWOT Analysis
7. 10.7 Astellas Pharma
  1. 10.7.1 Overview
  2. 10.7.2 Product/Business Segment Overview
  3. 10.7.3 Financials
  4. 10.7.4 Key Developments
  5. 10.7.5 SWOT Analysis
8. 10.7 GlaxoSmithKline plc
  1. 10.7.1 Overview
  2. 10.7.2 Product/Business Segment Overview
  3. 10.7.3 Financials
  4. 10.7.4 Key Developments
  5. 10.7.5 SWOT Analysis
9. 10.7 Abbott
  1. 10.7.1 Overview
  2. 10.7.2 Product/Business Segment Overview
  3. 10.7.3 Financials
  4. 10.7.4 Key Developments
  5. 10.7.5 SWOT Analysis
10. 10.7 Sigma-Aldrich
  1. 10.7.1 Overview
  2. 10.7.2 Product/Business Segment Overview
  3. 10.7.3 Financials
  4. 10.7.4 Key Developments
  5. 10.7.5 SWOT Analysis
11. 10.8 Others
11 Appendix
1. List of Tables
TABLE 1 MIDDLE EAST AND AFRICA ANTI-FUNGAL AGENTS MARKET, 2023-2030 (USD MILLION)
MEA Anti Fungal Agents Market, BY THERAPEUTIC INDICATION,2023-2030 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA MEA Anti Fungal Agents Market, BY DRUG CLASS, 2023-2030 (USD MILLION)
TABLE 4 MIDDLE MEA Anti Fungal Agents Market, BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
MEA Anti Fungal Agents Market, BY REGION, 2023-2030 (USD MILLION)
1. List of Figures
FIGURE 1 RESEARCH PROCESS
FIGURE 2 PORTERS FIVE FORCES MODEL
FIGURE 3 MIDDLE EAST AND AFRICA ANTI-FUNGAL MEA Anti Fungal Agents Market, BY THERAPEUTIC INDICATION
FIGURE 4 MIDDLE EAST AND AFRICA ANTI-FUNGAL MEA Anti Fungal Agents Market, BY DRUG CLASS
FIGURE 5 MIDDLE EAST AND AFRICA ANTI-FUNGAL AGENTS MEA Anti Fungal Agents Market, BY ROUTE OF ADMINISTRATION
FIGURE 6 MIDDLE EAST AND AFRICA ANTI-FUNGAL MEA Anti Fungal Agents Market, BY REGION
FIGURE 7 MIDDLE EAST AND AFRICA ANTI-FUNGAL AGENTS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

Certified Researchers

Customize Report

Anti-Fungal Agents Market Segmentation

Market Segmentation Overview

Detailed segmentation data will be available in the full report
Comprehensive analysis by multiple parameters
Regional and country-level breakdowns
Market size forecasts by segment

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”